Reuben, Alexandre http://orcid.org/0000-0003-4510-0382
Zhang, Jiexin http://orcid.org/0000-0001-9526-6730
Chiou, Shin-Heng
Gittelman, Rachel M.
Li, Jun
Lee, Won-Chul http://orcid.org/0000-0003-3913-8632
Fujimoto, Junya
Behrens, Carmen
Liu, Xiaoke
Wang, Feng
Quek, Kelly http://orcid.org/0000-0002-8113-0944
Wang, Chunlin
Kheradmand, Farrah
Chen, Runzhe
Chow, Chi-Wan
Lin, Heather
Bernatchez, Chantale
Jalali, Ali
Hu, Xin
Wu, Chang-Jiun
Eterovic, Agda Karina
Parra, Edwin Roger http://orcid.org/0000-0001-9068-1636
Yusko, Erik
Emerson, Ryan
Benzeno, Sharon
Vignali, Marissa
Wu, Xifeng
Ye, Yuanqing
Little, Latasha D.
Gumbs, Curtis
Mao, Xizeng
Song, Xingzhi
Tippen, Samantha
Thornton, Rebecca L.
Cascone, Tina
Snyder, Alexandra
Wargo, Jennifer A. http://orcid.org/0000-0003-3438-7576
Herbst, Roy
Swisher, Stephen http://orcid.org/0000-0002-3080-1920
Kadara, Humam
Moran, Cesar
Kalhor, Neda
Zhang, Jianhua
Scheet, Paul
Vaporciyan, Ara A.
Sepesi, Boris
Gibbons, Don L.
Robins, Harlan
Hwu, Patrick
Heymach, John V.
Sharma, Padmanee
Allison, James P.
Baladandayuthapani, Veera
Lee, Jack J. http://orcid.org/0000-0001-5469-9214
Davis, Mark M. http://orcid.org/0000-0001-6868-657X
Wistuba, Ignacio I.
Futreal, P. Andrew http://orcid.org/0000-0001-8663-2671
Zhang, Jianjun
Funding for this research was provided by:
Welch Foundation
Howard Hughes Medical Institute
Article History
Received: 1 May 2019
Accepted: 17 December 2019
First Online: 30 January 2020
Competing interests
: R.M.G, E.Y, R.E., S.B, M.V. and A.S. have employment and equity ownership with Adaptive Biotechnologies. J.A.W. has honoraria from speakers' bureau of Dava Oncology and is an advisory board member for GlaxoSmithKline and Roche/Genentech. H.R. has employment, equity ownership, patents, and royalties with Adaptive Biotechnologies. P.H. serves on the advisory board of Iovance Biotherapeutics, Inc. and Immatics US. J.V.H. is a consultant for AstraZeneca, Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Medivation, ARIAD, Synta, Oncomed, Novartis, Genentech, and Calithera Biosciences, holds stock in Cardinal Spine LLC and Bio-Tree, and has received funding from AstraZeneca. P.S. is a consultant for Bristol-Myers Squibb, Jounce Therapeutics, Helsinn, and GlaxoSmithKline as well as a stockholder from Jounce Therapeutics. J.P.A. is a consultant and stockholder for Jounce Therapeutics, receives royalties from Bristol-Myers Squibb, and has intellectual property with Bristol-Myers Squibb and Merck. I.I.W. receives honoraria from Roche/Genentech, Ventana, GlaxoSmithKline, Celgene, Bristol-Myers Squibb, Synta Pharmaceuticals, Boehringer Ingelheim, Medscape, Clovis, AstraZeneca, and Pfizer, and research support from Roche/Genentech, Oncoplex, and HGT. All remaining authors report no conflicts of interest.